SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000932440-07-000666
Filing Date
2007-11-13
Accepted
2007-11-13 11:10:17
Documents
3
Group Members
RIDGEBACK CAPITAL MANAGEMENT LLCWAYNE HOLMAN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13-g_1247896.htm SC 13G 168972
2 EXHIBIT 24.1 exh24-1_1247618.htm EX-24 5431
3 EXHIBIT 99.1 exh99-1_1247900.htm EX-99 15182
  Complete submission text file 0000932440-07-000666.txt   191655
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Subject) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81457 | Film No.: 071235616
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022
Business Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022 212-624-2567
Ridgeback Capital Investments Ltd. (Filed by) CIK: 0001358916 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G